Evidence map›Paper›PMID 38340254›Full record

ArticleNano convergence2024

Effect of gut microbiota-derived metabolites and extracellular vesicles on neurodegenerative disease in a gut-brain axis chip.

Na Yeon Kim, Ho Yeon Lee, Yoon Young Choi, Sung Jun Mo, Soomin Jeon, Jang Ho Ha, Soo Dong Park, Jae-Jung Shim, Jaehwan Lee, Bong Geun Chung

Abstract read
In one paragraph

Article in Nano convergence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Review
  2. Review
  3. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Frontiers in microbiology · 2026
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Na Yeon Kim *Department of Biomedical Engineering, Sogang University, Seoul, Korea.
Ho Yeon Lee *Department of Biomedical Engineering, Sogang University, Seoul, Korea.
Yoon Young Choi *Institute of Integrated Biotechnology, Sogang University, Seoul, Korea.
Sung Jun MoR&BD Center, hy Co., Ltd., Yongin, Korea.
Soomin JeonR&BD Center, hy Co., Ltd., Yongin, Korea.
Jang Ho HaDepartment of Mechanical Engineering, Sogang University, Seoul, Korea.
Soo Dong ParkR&BD Center, hy Co., Ltd., Yongin, Korea.
Jae-Jung ShimR&BD Center, hy Co., Ltd., Yongin, Korea.
Jaehwan LeeR&BD Center, hy Co., Ltd., Yongin, Korea.
Bong Geun ChungDepartment of Biomedical Engineering, Sogang University, Seoul, Korea. bchung@sogang.ac.kr.ORCID http://orcid.org/0000-0002-6838-3218

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new perspective suggests that a dynamic bidirectional communication system, often referred to as the microbiome-gut-brain axis, exists among the gut, its microbiome, and the central nervous system (CNS). This system may influence brain health and various brain-related diseases, especially in the realms of neurodevelopmental and neurodegenerative conditions. However, the exact mechanism is not yet understood. Metabolites or extracellular vesicles derived from microbes in the gut have the capacity to traverse the intestinal epithelial barrier or blood-brain barrier, gaining access to the systemic circulation. This phenomenon can initiate the physiological responses that directly or indirectly impact the CNS and its function. However, reliable and controllable tools are required to demonstrate the causal effects of gut microbial-derived substances on neurogenesis and neurodegenerative diseases. The integration of microfluidics enhances scientific research by providing advanced in vitro engineering models. In this study, we investigated the impact of microbe-derived metabolites and exosomes on neurodevelopment and neurodegenerative disorders using human induced pluripotent stem cells (iPSCs)-derived neurons in a gut-brain axis chip. While strain-specific, our findings indicate that both microbial-derived metabolites and exosomes exert the significant effects on neural growth, maturation, and synaptic plasticity. Therefore, our results suggest that metabolites and exosomes derived from microbes hold promise as potential candidates and strategies for addressing neurodevelopmental and neurodegenerative disorders.

Indexed as

ExosomeExtracellular vesiclesGut-brain axis chipHuman iPSCsMetabolitesNeural differentiationNeurodegenerative disease

Identifiers

PMID38340254
PMCPMC10858859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.